Regenerative Medical Technology RMTG
OTC RMTG
$0.03 +0.00 (+0.00%)
At close: Nov 10, 2026 · 4:00 PM EST

Regenerative Medical Technology (RMTG) Return on Sales [ROS] (2018 - 2026)

Updated

Regenerative Medical Technology's Return on Sales [ROS] was 14.07% in Q2 2026, up 39.50 percentage points from -25.43% a year earlier and up 5.36 percentage points from the prior quarter.

Analysis

Regenerative Medical Technology (RMTG) Return on Sales [ROS] (2018 - 2026) Analysis & Trends

On a trailing twelve-month basis, Regenerative Medical Technology's Return on Sales [ROS] was 0.46% through Jun 30, 2026, down 5.42 percentage points year-over-year; for FY2025, it came in at -17.00%, down 18.98 percentage points from FY2024.

  • Return on Sales [ROS] shows a five-year change of +797.09 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Sales [ROS] was 1.98% in FY2024 (+31.65 pp), -29.68% in FY2023 (+47.75 pp), -77.43% in FY2022 (+2187.89 pp) and -2265.32% in FY2021 (-1451.23 pp).
  • The Q2 2026 figure marks the highest quarterly Return on Sales [ROS] since Q4 2024.
  • Compared with a year earlier, Return on Sales [ROS] was higher in five of the last eight quarters, with an average year-over-year change of +4.87 percentage points.
  • The best year-over-year quarter for Return on Sales [ROS] over five years was Q3 2022 (a gain of 5418.52 percentage points); the worst was Q3 2021 (a drop of 5066.37 percentage points).
  • Per Business Quant data, RMTG's Return on Sales [ROS] in the three quarters before Q2 2026 was 8.71% (Q1 2026), -19.48% (Q4 2025) and -37.76% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 Regenerative Medical Technology 412,169.03 -4.11 Mn 2.58 Mn 14.07%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14.07%
Mar 31, 2026 8.71%
Dec 31, 2025 -19.48%
Sep 30, 2025 -37.76%
Jun 30, 2025 -25.43%
Mar 31, 2025 9.89%
Dec 31, 2024 25.19%
Sep 30, 2024 1.99%
Jun 30, 2024 -26.97%
Mar 31, 2024 -12.86%
Dec 31, 2023 -21.95%
Sep 30, 2023 -11.60%
Jun 30, 2023 -119.23%
Mar 31, 2023 -9.44%
Dec 31, 2022 -20.34%
Sep 30, 2022 -43.97%
Jun 30, 2022 -122.89%
Mar 31, 2022 -181.55%
Dec 31, 2021 -196.56%
Sep 30, 2021 -5,462.49%
API Access

Regenerative Medical Technology Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=RMTG&period=max&api_key=YOUR_API_KEY